We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+5.54%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$228M
AUM Growth
+$28.2M
Cap. Flow
+$16.3M
Cap. Flow %
7.18%
Top 10 Hldgs %
22.49%
Holding
2,261
New
155
Increased
919
Reduced
268
Closed
73

Top Buys

Rank Stock Value
1
VTI icon
Vanguard Total Stock Market ETF
VTI
+$3.24M
2
VIVO
Meridian Bioscience Inc
VIVO
+$2.22M
3
VGT icon
Vanguard Information Technology ETF
VGT
+$1.31M
4
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$1.05M
5
MLPI
UBS E-TRACS Alerian MLP Infrastructure ETN
MLPI
+$1.04M

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$12.5M
2
HD icon
Home Depot
HD
+$5.18M
3
IWB icon
iShares Russell 1000 ETF
IWB
+$555K
4
ESRX
Express Scripts Holding Company
ESRX
+$401K
5
IWM icon
iShares Russell 2000 ETF
IWM
+$401K

Sector Composition

Rank Sector Weight
1 Financials 10.77%
2 Healthcare 8.96%
3 Consumer Staples 8.9%
4 Technology 8.86%
5 Industrials 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PSX icon
226
Phillips 66
PSX
$82.9B
$153K 0.07%
2,048
+61
+3% +$4.91K
ANZ
227
DELISTED
AUSTRALIA & NW ZEAL ADS(RP5 SH
ANZ
$151K 0.07%
6,741
+2,602
+63% +$58.3K
FMS icon
228
Fresenius Medical Care
FMS
$13.2B
$149K 0.07%
3,736
+420
+13% +$17.4K
ROP icon
229
Roper Technologies
ROP
$36.3B
$147K 0.06%
732
+29
+4% +$5.81K
GOLD
230
DELISTED
Randgold Resources Ltd
GOLD
$146K 0.06%
1,744
+1,414
+428% +$123K
NMR icon
231
Nomura Holdings
NMR
$28.7B
$145K 0.06%
24,586
+13,561
+123% +$86.9K
BT
232
DELISTED
BT Group plc (ADR)
BT
$145K 0.06%
7,474
+6,254
+513% +$131K
VSM
233
DELISTED
Versum Materials, Inc.
VSM
$143K 0.06%
4,858
-235
-5% -$6.86K
PRU icon
234
Prudential Financial
PRU
$41.7B
$139K 0.06%
1,376
+137
+11% +$14.8K
AZN icon
235
AstraZeneca
AZN
$263B
$138K 0.06%
2,296
+1,403
+157% +$81.7K
CE icon
236
Celanese
CE
$5.09B
$138K 0.06%
1,551
– –
FITB
237
Fifth Third Bancorp
FITB
$52B
$138K 0.06%
5,581
+370
+7% +$9.86K
PNR icon
238
Pentair
PNR
$10.2B
$138K 0.06%
3,382
– –
VRSN icon
239
VeriSign
VRSN
$25.3B
$138K 0.06%
1,624
– –
DEO icon
240
Diageo
DEO
$46.2B
$137K 0.06%
1,249
+1,013
+429% +$114K
EQNR icon
241
Equinor
EQNR
$95.9B
$137K 0.06%
8,327
+6,801
+446% +$122K
MET icon
242
MetLife
MET
$61B
$137K 0.06%
3,023
-469
-13% -$22.4K
SBUX icon
243
Starbucks
SBUX
$118B
$137K 0.06%
2,489
+207
+9% +$11.7K
PX
244
DELISTED
Praxair Inc
PX
$137K 0.06%
1,208
+47
+4% +$5.53K
IX icon
245
ORIX
IX
$44B
$136K 0.06%
9,835
+6,260
+175% +$97.1K
RACE icon
246
Ferrari
RACE
$63.3B
$136K 0.06%
1,952
+1,276
+189% +$82.9K
STLA icon
247
Stellantis
STLA
$16.5B
$135K 0.06%
12,757
+12,438
+3,899% +$134K
TFC icon
248
Truist Financial
TFC
$63.2B
$135K 0.06%
3,152
+79
+3% +$3.69K
DLTR icon
249
Dollar Tree
DLTR
$23.1B
$134K 0.06%
1,769
+134
+8% +$10.3K
EFA icon
250
iShares MSCI EAFE ETF
EFA
$76.4B
$133K 0.06%
2,147
– –
8 9
10
11 12

Similar funds

BDLIB
Banque de Luxembourg Investments (BLI) Luxembourg City, Luxembourg $3.34B AUM 11.13% 1-Year Est. Return
CS
CapitalatWork SA Auderghem $3.35B AUM
ECA
Encompass Capital Advisors New York $3.34B AUM 167.64% 1-Year Est. Return
TAM
Troy Asset Management London, United Kingdom $3.35B AUM 11.7% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
HP
Hancock Prospecting West Perth, Australia $3.33B AUM 65.96% 1-Year Est. Return
EFM
E Fund Management Guangzhou, China $3.37B AUM

Quadrant Capital Group's Q1 2017 Portfolio in Review

As of Q1 2017, Quadrant Capital Group held 2,261 positions worth $228M, up 14% from $199M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Quadrant Capital Group deployed $16.3M of net new capital in Q1 2017, opening 155 new positions and adding to 919 existing holdings. Its largest new stake was Meridian Bioscience Inc: 158,483 shares worth $2.19M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Procter & Gamble, an estimated $12.5M trimmed.

  • Quadrant Capital Group's largest Q1 2017 buy was Meridian Bioscience Inc: 158,483 shares worth $2.19M.
  • Quadrant Capital Group added most to Vanguard Total Stock Market ETF in Q1 2017, an estimated $3.24M increase.
  • Quadrant Capital Group's biggest Q1 2017 reduction was Procter & Gamble, cutting an estimated $12.5M.
  • Quadrant Capital Group fully exited Harman International Industries in Q1 2017, selling an estimated $104K.
  • Quadrant Capital Group's ten largest holdings make up 22% of its $228M portfolio in Q1 2017.
  • Quadrant Capital Group opened 155 new positions and closed 73 in Q1 2017.
  • Quadrant Capital Group's portfolio value rose 14% quarter-over-quarter to $228M.

Based on Quadrant Capital Group's 13F filing for Q1 2017, filed 10 Apr 2017.